This product eliminates fermentation residues and other metabolic toxins, and has stable quality. But it is not a single component, it mainly contains 70%~80% of the M1 component (M1 M1 is a macrolide, S1 is a substituted block. The respective antibacterial ranges are different, virginiamycin is M1 factor and S1 factor The minimum inhibitory concentration (MIC) of the separate M1 part against Staphylococcus aureus is 0.25μg/ml, the S1 part is 4μg/ml, and the compound is 0.125μg/ml, which improves the sterilization effect by 1~ 30 times. The M1 component is named because it is most effective against Micrococcus aureus. The S1 component is named because it is most effective against Sarcina lutea. M1: S1 = 70:30, when this ratio is composed, the antibacterial activity is the highest. Because of the different structures of these two components, bacteria that produce S1 synthesis are still very sensitive to the M1 component, so virginiamycin has almost no reproducibility.


  It only has an inhibitory effect on Gram-positive bacteria. The mechanism of action is to inhibit the ribosome (ribosome) of the bacteria, and prevent it from achieving a bactericidal effect on protein synthesis. Oral LD50 for rats is 7 500 mg per milligram of body weight, and one-time oral administration. When the dose for mice reaches 1 550 mg per dose, no harmful reactions are found. The maximum safe dose for pigs is 800 mg per body weight. The pigs were fed with a dose of 500 mg for 3 months without adverse reactions.